Results 51 to 60 of about 1,677 (134)

IDENTIFICATION OF RELATIONSHIP PAINFUL ERECTION WITH DEPRESSION AND ANXIETY IN PATIENTS WITH PEYRONIE'S DISEASE

open access: yesВестник урологии, 2016
The prevalence of Peyronie's disease is about 10% of the male population of 100 thousand. Since, according to the polls 77% of men suffering from this disease, the deterioration of the quality of life in general, which is connected not only with the ...
M. K. Alchinbayev   +3 more
doaj   +1 more source

Urine‐Derived Stem Cells: Applications of Paracrine‐Driven Regeneration and Functional Recovery in Multiorgan Systems

open access: yesStem Cells International, Volume 2026, Issue 1, 2026.
Stem cell therapy, a highly recognized approach in the field of regenerative medicine, is known for its potential to stimulate the self‐healing process of the body using stem cells or their derivatives, in which urine‐derived stem cells (USCs) stand out as a novel and promising tool in treating various diseases recently.
Dan Li   +6 more
wiley   +1 more source

Peyronie's disease in the United States: A real‐world, 13‐year nationwide analysis of demographics, clinical characteristics, and treatment trends

open access: yesAndrology, Volume 13, Issue 8, Page 2265-2272, November 2025.
Abstract Background Real‐world data on Peyronie's disease remains limited. Objectives Describe the demographics, clinical characteristics, and therapeutic management of Peyronie's disease patients in the United States. Materials and methods A retrospective analysis was conducted using the PearlDiver Mariner database (2010–2022).
Angelo Orsini   +15 more
wiley   +1 more source

TREATMENT OF PEYRONIE'S DISEASE

open access: yesМедицина в Кузбассе, 2017
Here we present a review of global data on known methods of treatment of Peyronie's disease. A comparative analysis of surgical techniques is performed.
Павел Сергеевич Кызласов   +4 more
doaj  

Peyronie’s Disease: Still a Surgical Disease

open access: yesAdvances in Urology, 2012
Peyronie’s Disease (PD) remains a challenging and clinically significant morbid condition. Since its first description by François Gigot de la Peyronie, much of the treatment for PD remains nonstandardized. PD is characterized by the formation of fibrous
Daniel Martinez   +4 more
doaj   +1 more source

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners

open access: yesSexual Medicine, 2017
Introduction: Collagenase Clostridium histolyticum (CCH) intralesional injection was efficacious for the management of Peyronie's disease (PD) in the double-blinded, randomized, placebo-controlled Investigation for Maximal Peyronie's Reduction Efficacy ...
Irwin Goldstein, MD   +5 more
doaj   +1 more source

A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study

open access: yesInternational Brazilian Journal of Urology
Objectives: To compare the response to tiocolchicine and verapamil injection in the plaque of patients with Peyronie's disease. Materials and Methods: Prospective, single-blind, randomized study, selecting patients who have presented Peyronie's disease ...
I. L. Toscano Jr.   +5 more
doaj   +1 more source

ETIOLOGY, PATHOGENESIS AND CLINICAL DIAGNOSIS OF PEYRONIE’S DISEASE

open access: yesМедицина в Кузбассе, 2017
Peyronie’s disease remains an understudied progressing disease being  one of the relevant problems of modern urology and andrology. This condition may cause erectile dysfunction in men of fertile age and its negative impact on sexual function adversely ...
Тарас Валерьевич Шатылко   +3 more
doaj  

The use of penile traction therapy in the management of Peyronie's disease: current evidence and future prospects

open access: yesTherapeutic Advances in Urology, 2019
Peyronie’s disease is a disorder of abnormal and dysregulated wound healing leading to scar formation in the tunica albuginea of the penis. Penile traction therapy has emerged as an attractive therapeutic option for men with Peyronie’s disease in both ...
Robert Valenzuela   +3 more
doaj   +1 more source

Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie’s disease

open access: yesKaohsiung Journal of Medical Sciences, 2017
Inflammation is mechanistically involved in the development of Peyronie’s disease (PD). The aim of this study is to assess the relevance of serum pentraxin 3 (PTX3) and interleukin-6 (IL-6) concentrations in PD.
Arda Atar   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy